invoX Pharma completed the spin-off of F-star.

invoX Pharma, a biopharmaceutical company, completed the spin-off of F-star, a clinical-stage biopharmaceutical company. Financial terms were not disclosed. "We are pleased to announce that F-star Therapeutics has entered a new chapter in our history and become a private, independent company, fully owned and operated by the existing management team. The mission remains unchanged – using our proven, world-leading bispecific platform to discover next-generation therapeutics both for our internal pipeline and our collaboration partners."